Nuvalent Inc-a
(NUVL)
|
7.7 |
$368M |
|
19M |
19.04 |
Viatris
(VTRS)
|
5.9 |
$281M |
|
21M |
13.53 |
Adapthealth Corp Common Stock
(AHCO)
|
5.2 |
$250M |
|
10M |
24.46 |
Glaukos Corp Note 2.750% 6/1 (Principal)
|
5.1 |
$242M |
|
205M |
1.18 |
Invitae Corp Note 2.000% 9/0 (Principal)
|
3.2 |
$153M |
|
163M |
0.94 |
Aerie Pharmaceuticals Note 1.500%10/0 (Principal)
|
2.7 |
$130M |
|
157M |
0.83 |
Caremax Com Cl A
|
2.7 |
$129M |
|
17M |
7.68 |
Neurocrine Biosciences
(NBIX)
|
2.5 |
$117M |
|
1.4M |
85.17 |
Envista Holdings Corporation Note 2.375% 6/0 (Principal)
|
2.4 |
$117M |
|
53M |
2.22 |
Natera Note 2.250% 5/0 (Principal)
|
2.4 |
$116M |
|
45M |
2.57 |
Singular Genomics Systems In
|
2.2 |
$105M |
|
9.1M |
11.56 |
Nuvasive Note 1.000% 6/0 (Principal)
|
2.0 |
$97M |
|
97M |
1.00 |
Pacira Biosciences Note 0.750% 8/0 (Principal)
|
1.9 |
$91M |
|
82M |
1.11 |
Centene Corporation
(CNC)
|
1.7 |
$83M |
|
1.0M |
82.40 |
Tabula Rasa Healthcare Note 1.750% 2/1 (Principal)
|
1.7 |
$81M |
|
98M |
0.82 |
Iveric Bio
|
1.7 |
$80M |
|
4.8M |
16.72 |
Organogenesis Hldgs
(ORGO)
|
1.6 |
$78M |
|
8.5M |
9.24 |
Insulet Corp Note 0.375% 9/0 (Principal)
|
1.6 |
$76M |
|
58M |
1.33 |
Pulmonx Corp
(LUNG)
|
1.6 |
$76M |
|
2.4M |
32.07 |
Nuvasive Note 0.375% 3/1 (Principal)
|
1.6 |
$75M |
|
78M |
0.96 |
Nevro Corp Note 2.750% 4/0 (Principal)
|
1.4 |
$68M |
|
61M |
1.12 |
Silk Road Medical Inc Common
|
1.4 |
$65M |
|
1.5M |
42.61 |
Larimar Therapeutics
(LRMR)
|
1.3 |
$63M |
|
5.8M |
10.79 |
Sema4 Holdings Corp Com Cl A
|
1.3 |
$62M |
|
14M |
4.46 |
Edgewise Therapeutics
(EWTX)
|
1.3 |
$60M |
|
3.9M |
15.28 |
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
1.2 |
$59M |
|
80M |
0.74 |
Deciphera Pharmaceuticals
|
1.1 |
$55M |
|
5.6M |
9.77 |
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
|
1.1 |
$54M |
|
58M |
0.94 |
Apria
|
1.1 |
$54M |
|
1.7M |
32.60 |
Glaukos
(GKOS)
|
1.1 |
$54M |
|
1.2M |
44.44 |
Mirum Pharmaceuticals
(MIRM)
|
1.1 |
$52M |
|
3.3M |
15.95 |
Insmed Note 1.750% 1/1 (Principal)
|
1.1 |
$51M |
|
50M |
1.03 |
Kura Oncology
(KURA)
|
1.0 |
$49M |
|
3.5M |
14.00 |
Apellis Pharmaceuticals Note 3.500% 9/1 (Principal)
|
0.9 |
$44M |
|
29M |
1.51 |
Molina Healthcare
(MOH)
|
0.9 |
$43M |
|
135k |
318.08 |
Alphatec Hldgs Com New
(ATEC)
|
0.9 |
$41M |
|
3.6M |
11.43 |
Protagonist Therapeutics
(PTGX)
|
0.8 |
$40M |
|
1.2M |
34.20 |
Day One Biopharmaceuticals I
(DAWN)
|
0.8 |
$37M |
|
2.2M |
16.85 |
Cytokinetics Com New
(CYTK)
|
0.8 |
$37M |
|
809k |
45.58 |
Pacira Pharmaceuticals
(PCRX)
|
0.8 |
$36M |
|
596k |
60.17 |
Novavax Note 3.750% 2/0 (Principal)
|
0.7 |
$34M |
|
25M |
1.38 |
Xilio Therapeutics
(XLO)
|
0.7 |
$34M |
|
2.2M |
15.66 |
Aerie Pharmaceuticals
|
0.7 |
$33M |
|
4.7M |
7.02 |
Oncology Institu
(TOI)
|
0.7 |
$32M |
|
3.3M |
9.75 |
Nuvation Bio Com Cl A
(NUVB)
|
0.6 |
$30M |
|
3.6M |
8.50 |
Springworks Therapeutics
(SWTX)
|
0.6 |
$28M |
|
452k |
61.98 |
Esperion Therapeutics
(ESPR)
|
0.5 |
$25M |
|
5.0M |
5.00 |
BioCryst Pharmaceuticals
(BCRX)
|
0.5 |
$23M |
|
1.7M |
13.85 |
Meridian Bioscience
|
0.5 |
$23M |
|
1.1M |
20.40 |
Figs Cl A
(FIGS)
|
0.5 |
$23M |
|
830k |
27.56 |
Pharvaris N V
(PHVS)
|
0.5 |
$23M |
|
1.6M |
14.39 |
Revolution Medicines
(RVMD)
|
0.5 |
$22M |
|
892k |
25.17 |
Brookdale Senior Living
(BKD)
|
0.5 |
$22M |
|
4.3M |
5.16 |
Alector
(ALEC)
|
0.5 |
$22M |
|
1.1M |
20.65 |
Health Catalyst Note 2.500% 4/1 (Principal)
|
0.5 |
$22M |
|
15M |
1.45 |
Xeris Biopharma Holdings Note 5.000% 7/1 (Principal)
|
0.5 |
$22M |
|
18M |
1.20 |
Bellus Health Com New
|
0.4 |
$20M |
|
2.4M |
8.05 |
Profound Med Corp Com New
(PROF)
|
0.4 |
$19M |
|
1.7M |
11.23 |
Rhythm Pharmaceuticals
(RYTM)
|
0.4 |
$19M |
|
1.9M |
9.98 |
Outset Med
(OM)
|
0.4 |
$19M |
|
401k |
46.09 |
Nevro
(NVRO)
|
0.4 |
$18M |
|
216k |
81.07 |
Kinnate Biopharma
|
0.4 |
$18M |
|
986k |
17.72 |
Bridgebio Pharma Call Option
(BBIO)
|
0.3 |
$17M |
|
1.0M |
16.68 |
Oncorus
|
0.3 |
$17M |
|
3.1M |
5.27 |
Terns Pharmaceuticals
(TERN)
|
0.3 |
$17M |
|
2.3M |
7.07 |
Apellis Pharmaceuticals
(APLS)
|
0.3 |
$16M |
|
343k |
47.28 |
Inozyme Pharma
(INZY)
|
0.3 |
$16M |
|
2.3M |
6.82 |
Da32 Life Scnce Tec Acqstn C Class A Com
|
0.3 |
$16M |
|
1.6M |
9.81 |
Kalvista Pharmaceuticals
(KALV)
|
0.3 |
$16M |
|
1.2M |
13.23 |
Ptc Therapeutics Note 3.000% 8/1 (Principal)
|
0.3 |
$15M |
|
15M |
1.05 |
Apollo Endosurgery
|
0.3 |
$15M |
|
1.8M |
8.43 |
Vincerx Pharma Com New
(VINC)
|
0.3 |
$14M |
|
1.4M |
10.19 |
Merus N V
(MRUS)
|
0.3 |
$14M |
|
437k |
31.80 |
Cogent Biosciences
(COGT)
|
0.3 |
$14M |
|
1.6M |
8.58 |
Mirati Therapeutics
|
0.3 |
$13M |
|
88k |
146.69 |
Sarepta Therapeutics
(SRPT)
|
0.3 |
$13M |
|
141k |
90.05 |
Pmv Pharmaceuticals
(PMVP)
|
0.3 |
$12M |
|
522k |
23.10 |
Blueprint Medicines
(BPMC)
|
0.2 |
$12M |
|
110k |
107.11 |
Werewolf Therapeutics
(HOWL)
|
0.2 |
$11M |
|
958k |
11.91 |
Quantum Si Com Cl A
(QSI)
|
0.2 |
$11M |
|
1.4M |
7.87 |
Lianbio Sponsored Ads
(LIANY)
|
0.2 |
$11M |
|
1.8M |
6.16 |
Nyxoah S A SHS
(NYXH)
|
0.2 |
$11M |
|
455k |
23.00 |
Cullinan Oncology
(CGEM)
|
0.2 |
$10M |
|
672k |
15.43 |
Medtech Acquisition Corp Com Cl A
|
0.2 |
$9.9M |
|
1000k |
9.88 |
Sarissa Capital Acquisitn Cl A
|
0.2 |
$9.8M |
|
1000k |
9.79 |
Eucrates Biomedical Acqu Cor SHS
|
0.2 |
$9.8M |
|
1000k |
9.76 |
Senior Connect Acquisitn Cor Com Cl A
|
0.2 |
$9.7M |
|
1.0M |
9.74 |
Revolution Healthcar Aq Corp Class A Com
|
0.2 |
$9.7M |
|
1.0M |
9.74 |
Graybug Vision Com Shs
|
0.2 |
$9.7M |
|
5.3M |
1.83 |
Orchard Therapeutics Ads
|
0.2 |
$9.2M |
|
6.9M |
1.32 |
Acutus Medical
(AFIB)
|
0.2 |
$9.0M |
|
2.6M |
3.41 |
Weave Communications
(WEAV)
|
0.2 |
$8.4M |
|
555k |
15.18 |
Guardant Health Note 11/1 (Principal)
|
0.2 |
$8.1M |
|
8.0M |
1.01 |
Privia Health Group
(PRVA)
|
0.2 |
$7.8M |
|
300k |
25.87 |
Turmeric Acquisition Corp Cl A
|
0.2 |
$7.4M |
|
750k |
9.82 |
Hyperfine Com Cl A
(HYPR)
|
0.2 |
$7.3M |
|
1.0M |
7.25 |
Ignyte Acquisition Corp
|
0.1 |
$7.1M |
|
725k |
9.74 |
Definitive Healthcare Corp Class A Com
(DH)
|
0.1 |
$6.8M |
|
250k |
27.33 |
Annexon
(ANNX)
|
0.1 |
$6.7M |
|
584k |
11.49 |
Benefitfocus Note 1.250%12/1
|
0.1 |
$6.2M |
|
6.5M |
0.96 |
American Well Corp Cl A
|
0.1 |
$6.0M |
|
991k |
6.04 |
Bioatla
(BCAB)
|
0.1 |
$5.7M |
|
289k |
19.63 |
Orion Acquisition Corp Com Cl A
|
0.1 |
$4.9M |
|
500k |
9.78 |
Delcath Sys Com New
(DCTH)
|
0.1 |
$3.9M |
|
500k |
7.75 |
Pyxis Oncology Common Stock
(PYXS)
|
0.1 |
$3.4M |
|
312k |
10.97 |
Neogenomics Note 0.250% 1/1 (Principal)
|
0.0 |
$2.1M |
|
2.5M |
0.85 |
Roivant Sciences *w Exp 09/30/202
|
0.0 |
$2.0M |
|
1.0M |
2.05 |
Cabaletta Bio
(CABA)
|
0.0 |
$1.8M |
|
464k |
3.79 |
Wave Life Sciences SHS
(WVE)
|
0.0 |
$1.7M |
|
553k |
3.14 |
Medavail Holdings Ord
|
0.0 |
$1.6M |
|
1.1M |
1.40 |
Caremax *w Exp 06/08/202
(CMAXW)
|
0.0 |
$941k |
|
672k |
1.40 |
Butterfly Network *w Exp 02/12/202
(BFLY.WS)
|
0.0 |
$931k |
|
733k |
1.27 |
The Oncology Institute *w Exp 11/15/202
(TOIIW)
|
0.0 |
$863k |
|
1.3M |
0.69 |
Quantum Si *w Exp 06/10/202
(QSIAW)
|
0.0 |
$600k |
|
333k |
1.80 |
Somalogic *w Exp 08/31/202
|
0.0 |
$401k |
|
120k |
3.34 |
Nuvation Bio *w Exp 07/07/202
(NUVB.WS)
|
0.0 |
$315k |
|
167k |
1.89 |
Ignyte Acquisition Corp *w Exp 01/05/202
|
0.0 |
$279k |
|
363k |
0.77 |
Senior Connect Acquisitn Cor *w Exp 12/31/202
|
0.0 |
$263k |
|
500k |
0.53 |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202
|
0.0 |
$193k |
|
333k |
0.58 |
Surrozen *w Exp 08/01/203
(SRZNW)
|
0.0 |
$192k |
|
167k |
1.15 |
Medtech Acquisition Corp *w Exp 12/22/202
|
0.0 |
$174k |
|
333k |
0.52 |
Turmeric Acquisition Corp *w Exp 10/08/202
|
0.0 |
$170k |
|
250k |
0.68 |
Revolution Healthcar Aq Corp *w Exp 12/31/202
|
0.0 |
$150k |
|
200k |
0.75 |
BioDelivery Sciences International
|
0.0 |
$91k |
|
29k |
3.12 |
Orion Acquisition Corp *w Exp 02/19/202
|
0.0 |
$81k |
|
125k |
0.65 |
Windtree Therapeutics
|
0.0 |
$32k |
|
20k |
1.59 |